Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.

Slides:

Advertisements

Similar presentations

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Advertisements

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Anticoagulation of Bioprosthetic Aortic Valves.

Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study Eirik.

Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial Torbjørn Omland, MD, PHD, MPH, Marc S.

Volume 82, Issue 12, Pages (December 2012)

Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:

Elevated Uric Acid Increases the Risk for Acute Kidney Injury

Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Copyright © 2005 American Medical Association. All rights reserved.

Nat. Rev. Cardiol. doi: /nrcardio

Copyright © 2011 American Medical Association. All rights reserved.

FIGURE 1 Flow chart of the study population

Copyright © 2006 American Medical Association. All rights reserved.

Treatment of acute renal failure

Volume 1: Chronic Kidney Disease

Fig. 3 Summary estimates of the relative risks for the different surgical techniques for late mortality. Comparing the two main techniques, EVR showed.

First time a CETP inhibitor shows reduction of serious CV events

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate Szu-Yuan Li, MD, Chiao-Lin Chuang, MD,

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.

Chapter 4: Cardiovascular Disease in Patients with CKD

Volume 89, Issue 6, Pages (June 2016)

Step Care Therapy for Hypertension in Diabetic Patients

Volume 93, Issue 4, Pages (April 2018)

Dileep Raman et al. JACEP 2017;3:

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008 Colin R. Lenihan, MBBCh, BAO, Maria E. Montez-Rath,

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Volume 82, Issue 12, Pages (December 2012)

Propofol as a panacea for acute kidney injury?

Fig. 2. Evidence-based medication prescriptions

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery Maral Ouzounian, MD, Karen J. Buth, MS,

Juan J. Russo et al. JACC 2019;73:

New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton,

Nat. Rev. Cardiol. doi: /nrcardio

Transfusion Increases the Risk for Vasoplegia After Cardiac Operations

Optimal timing of coronary artery bypass after acute myocardial infarction: A review of California discharge data Eric S. Weiss, MD, David D. Chang,

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Treatment of acute renal failure

Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor.

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.

Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.

CANVAS programe subanalyses HR (95%CI): 0.65 ( ) ( ) ( ) ( )

Volume 81, Issue 12, Pages (June 2012)

Adjusted relative risk Adjusted odds ratio

Guidance for the use of bilateral internal thoracic arteries according to survival benefit across age groups Umberto Benedetto, MD, PhD, Mohamed Amrani,

MRRs and EMRRs for women with ACS

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial Acute.

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Friends, social networks, and progressive chronic kidney disease

Propensity score-matching

Figure 7. Subgroup analysis according to the study design and support of CPB during CABG. The study design and support of CPB did not affect the results.

Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine.

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Effect of methylprednisolone versus placebo on the risk of acute kidney injury in a subsample of patients with serial postoperative serum creatinine assessments.

Risk of 30-day hospital encounter with ventricular arrhythmia

Change in 6 min walk distance at 12 months in subgroups defined by baseline characteristics. The mean (95% CI) for the difference between CABG and medical.

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

The Ottawa COPD (chronic obstructive pulmonary disease) Risk Scale (OCRS) is used in the emergency department (ED) to identify patients with acute COPD.

Presentation transcript:

Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Note: CI = confidence interval, RR = relative risk. *Adjusted for 9 prespecified covariates: age (years); sex; left ventricular function < 50%; diabetes; prerandomization use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, statins, or diuretics; surgery type (isolated valve [referent], isolated coronary artery bypass grafting [CABG], CABG and valve, or other); and evidence of nonelective surgery (defined as preoperative use of inotropes or vasopressors, preoperative use of an intra-aortic balloon pump or ventricular assist device, or evidence of myocardial infarction in the 30 days before surgery). †Chronic kidney disease was defined as a preoperative estimated glomerular filtration rate < 60 mL/min/1.73m2. The RR of acute kidney injury with methylprednisolone versus placebo was not statistically significantly different in those with versus without preoperative chronic kidney disease (p = 0.3 for interaction). Amit X. Garg et al. CMAJ 2019;191:E247-E256 ©2019 by Canadian Medical Association